{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:36:46Z","timestamp":1787668606538,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010098","name":"Shanghai Association for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.ejso.2019.08.021","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T11:33:04Z","timestamp":1566905584000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Predictive value of preoperative serum squamous cell carcinoma antigen (SCC\u2013Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study"],"prefix":"10.1016","volume":"46","author":[{"given":"Qinhao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhu","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9895","key":"10.1016\/j.ejso.2019.08.021_bib1","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.ejso.2019.08.021_bib2","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/ijc.28783","article-title":"Early detection of CIN3 and cervical cancer during long-term follow-up using HPV\/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme","volume":"135","author":"Luyten","year":"2014","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2019.08.021_bib3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2019.01.008","article-title":"Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer","volume":"153","author":"Kim","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"7645","key":"10.1016\/j.ejso.2019.08.021_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"Integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.ejso.2019.08.021_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/cncr.28055","article-title":"Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin","volume":"119","author":"Williams","year":"2013","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2019.08.021_bib7","first-page":"1660","article-title":"Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage","volume":"9","author":"Xu","year":"2018","journal-title":"J\u00a0Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2019.08.021_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186165","article-title":"The value of squamous cell carcinoma antigen (SCCa) to determine the lymph nodal metastasis in cervical cancer: a meta-analysis and literature review","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejso.2019.08.021_bib9","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/IGC.0000000000001112","volume":"27","author":"Xu","year":"2017","journal-title":"Int J Gynecol Cancer : official journal of the International Gynecological Cancer Society"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ygyno.2016.04.029","article-title":"Squamous cell carcinoma antigen (SCC-Ag) during follow-up of cervical cancer patients: role in the early diagnosis of recurrence","volume":"142","author":"Salvatici","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2018.03.056","article-title":"The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: a systematic review and meta-analysis","volume":"150","author":"Charakorn","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2019.08.021_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5468\/ogs.2018.61.3.337","article-title":"Optimal cutoff level of serum squamous cell carcinoma antigen to detect recurrent cervical squamous cell carcinoma during post-treatment surveillance","volume":"61","author":"Oh","year":"2018","journal-title":"Obstetrics & gynecology science"},{"issue":"5","key":"10.1016\/j.ejso.2019.08.021_bib13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5468\/ogs.2015.58.5.368","article-title":"The prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients","volume":"58","author":"Ryu","year":"2015","journal-title":"Obstetrics & gynecology science"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib14","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3802\/jgo.2019.30.e1","article-title":"Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis","volume":"30","author":"Choi","year":"2019","journal-title":"Journal of gynecologic oncology"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/bjc.2017.390","article-title":"Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer","volume":"118","author":"Markovina","year":"2018","journal-title":"Br J Canc"},{"issue":"3","key":"10.1016\/j.ejso.2019.08.021_bib16","first-page":"287","article-title":"Complementary roles of squamous cell carcinoma antigen and (18)F-FDG PET\/CT in suspected recurrence of cervical squamous cell cancer","volume":"6","author":"Hu","year":"2015","journal-title":"J\u00a0Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2019.08.021_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0002-9378(11)80037-2","article-title":"The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy","volume":"164","author":"Scambia","year":"1991","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejso.2019.08.021_bib18","first-page":"781","article-title":"Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging","volume":"100","author":"Ohara","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.ejso.2019.08.021_bib19","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/ijc.2910470311","article-title":"Squamous-cell carcinoma antigen (SCC-A) values related to clinical outcome of pre-invasive and invasive cervical carcinoma","volume":"47","author":"Brioschi","year":"1991","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2019.08.021_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/gyno.1994.1272","article-title":"Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix","volume":"55","author":"Bolli","year":"1994","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2019.08.021_bib21","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2005.02.123","article-title":"Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer","volume":"23","author":"Reesink-Peters","year":"2005","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22020","article-title":"The correlation between the serum squamous carcinoma antigen and the prognosis of recurrent cervical squamous carcinoma","volume":"31","author":"Wang","year":"2017","journal-title":"J\u00a0Clin Lab Anal"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1200\/JCO.1996.14.1.111","article-title":"Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma","volume":"14","author":"Duk","year":"1996","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ygyno.2007.08.091","article-title":"Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy","volume":"108","author":"Hirakawa","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.08.021_bib25","article-title":"Surveillance epidemiology and end results analysis demonstrates improvement in overall survival for cervical cancer patients treated in the era of concurrent chemoradiotherapy","volume":"581","author":"Hsu","year":"2015","journal-title":"Frontiers in oncology"},{"issue":"2","key":"10.1016\/j.ejso.2019.08.021_bib26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.21873\/anticanres.13190","article-title":"Radiation therapy for extrapelvic lymph node recurrence after curative treatment for cervical cancer","volume":"39","author":"Uno","year":"2019","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ejso.2019.08.021_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3857\/roj.2011.29.3.191","article-title":"The role of squamous cell carcinoma antigen as a prognostic and predictive factor in carcinoma of uterine cervix","volume":"29","author":"Jeong","year":"2011","journal-title":"Radiation oncology journal"},{"issue":"8","key":"10.1016\/j.ejso.2019.08.021_bib28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1200\/JCO.2000.18.8.1606","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"18","author":"Peters","year":"2000","journal-title":"J\u00a0Clin Oncol : official journal of the American Society of Clinical Oncology"},{"issue":"1","key":"10.1016\/j.ejso.2019.08.021_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3802\/jgo.2015.26.1.3","article-title":"Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors","volume":"26","author":"Matsuo","year":"2015","journal-title":"Journal of gynecologic oncology"},{"issue":"3","key":"10.1016\/j.ejso.2019.08.021_bib30","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4143\/crt.2017.346","article-title":"The prognostic impact of the number of metastatic lymph nodes and a new prognostic scoring system for recurrence in early-stage cervical cancer with high risk factors: a multicenter cohort study (KROG 15-04). Cancer research and treatment","volume":"50","author":"Kwon","year":"2018","journal-title":"official journal of Korean Cancer Association"},{"issue":"11","key":"10.1016\/j.ejso.2019.08.021_bib31","article-title":"Follow-up protocols for women with cervical cancer after primary treatment","author":"Lanceley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.ejso.2019.08.021_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MNM.0000000000000775","article-title":"The clinical value of PET and PET\/CT in the diagnosis and management of suspected cervical cancer recurrence","volume":"39","author":"Zhou","year":"2018","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.ejso.2019.08.021_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijrobp.2016.11.015","article-title":"Diffusion-weighted magnetic resonance imaging as a predictor of outcome in cervical cancer after chemoradiation","volume":"97","author":"Ho","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"17","key":"10.1016\/j.ejso.2019.08.021_bib34","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1002\/cncr.25991","article-title":"Impact of post-therapy positron emission tomography on prognostic stratification and surveillance after chemoradiotherapy for cervical cancer","volume":"117","author":"Siva","year":"2011","journal-title":"Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319306559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319306559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:32:12Z","timestamp":1760059932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319306559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0748798319306559"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.08.021","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive value of preoperative serum squamous cell carcinoma antigen (SCC\u2013Ag) level on tumor recurrence in cervical squamous cell carcinoma patients treated with radical surgery: A single-institution study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}